Boundless Bio Inc (BOLD) Stock Price, Quote & News

Company Profile

Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical trial in patients with estrogen receptor positive and human epidermal growth factor receptor 2 negative breast cancer, as well as patients with triple-negative breast cancer luminal androgen receptor s...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 766 9912

Website: boundlessbio.com

Address:

10955 Alexandria Way, Suite 100, San Diego, United States

AlertsAndNews Jul. 3 at 8:03 PM

$BOLD TANG Capital Management LLC (10%+) purchased 107,463 shares at an average price of $2.50 (Form 4). Another form 4 here.

0 · Reply

JuggernautRaider Jul. 1 at 8:09 AM

$BOLD $ATRA i cannot wait to short these turds. Flush the toilet!🚽

0 · Reply

JuggernautRaider Jun. 30 at 1:11 PM

$BOLD @race2zerodo you want to short this dying company?

0 · Reply

AlertsAndNews Jun. 30 at 2:54 AM

$BOLD quite the 10%+er buy TANG Capital Management LLC (10%+) purchased 286,333 shares at an average price of $2.50 (Form 4).

0 · Reply

ikkydiphoenix Jun. 30 at 12:21 AM

$BOLD https://ca.investing.com/news/stock-market-news/tang-capital-management-acquires-714768-of-boundless-bio-stock-93CH-4712818

0 · Reply

JuggernautRaider Jun. 29 at 8:26 PM

$BOLD might short this shit, why not. Theur CEO is below average at best

0 · Reply

stockanalysis_ Jun. 27 at 2:19 PM

Weekly Gainers: $ILLR $SDOT $FCUV $ATLN $BOLD

0 · Reply

bananastand1203 Jun. 25 at 2:35 PM

$PRME anyone selling given $BOLD news and upcoming arbitration outcome? Feeling that there are more headwind than positive developments in short term, with the greatest headwind being another dilutive raise

3 · Reply

DayTrade_4Life Jun. 25 at 7:55 AM

👀Some stocks to watch for 25 June: AMS AZI WAVE FMFC SKYQ $ICCM $BOLD $UBXG 👉See Profile to Join Us.

0 · Reply

Bootsy_Collins Jun. 24 at 2:40 PM

$BOLD Shorting back to a dollar

1 · Reply

Halper Sadeh LLC is Investigating Whether BOLD and NDRA are Obtaining Fair Deals for their Shareholders

NDRA

2026-06-23T13:43:46.000Z - 11 days ago

Boundless Bio, Serapha Bio to combine in all-stock merger

Jun 23, 2026, 8:30 AM EDT - 11 days ago

Boundless Bio Transcript: M&A announcement

Jun 23, 2026, 8:30 AM EDT - 11 days ago

Boundless Bio Press release: M&A announcement

Jun 23, 2026, 7:30 AM EDT - 11 days ago

Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement

2026-05-08T11:19:39.000Z - 2 months ago

Boundless Bio reports Q1 EPS (60c), consensus (56c)

May 8, 2026, 7:00 AM EDT - 2 months ago

Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights

May 8, 2026, 7:00 AM EDT - 2 months ago

Boundless Bio Quarterly report: Q1 2026

May 8, 2026, 7:00 AM EDT - 2 months ago

Boundless Bio Earnings release: Q1 2026

May 8, 2026, 7:00 AM EDT - 2 months ago

Boundless Bio Slides: Corporate presentation

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Boundless Bio Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Boundless Bio Proxy statement: Proxy filing

2026-04-17T21:00:47.000Z - 2 months ago

Boundless Bio presents preclinical data for BBI-940 therapy at AACR

Apr 17, 2026, 4:49 PM EDT - 2 months ago

Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting

Mar 17, 2026, 4:52 PM EDT - 3 months ago

Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026

Mar 11, 2026, 11:20 AM EDT - 4 months ago

Boundless Bio Transcript: Leerink Global Healthcare Conference 2026

2026-03-09T11:06:21.000Z - 4 months ago

Boundless Bio sees cash runway into 2H28

Mar 9, 2026, 7:00 AM EDT - 4 months ago

Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Mar 9, 2026, 7:00 AM EDT - 4 months ago

Boundless Bio Earnings release: Q4 2025

Mar 9, 2026, 7:00 AM EDT - 4 months ago

Boundless Bio Annual report: Q4 2025

Mar 9, 2026, 7:00 AM EDT - 4 months ago

Boundless Bio Slides: Corporate presentation

Mar 4, 2026, 7:00 AM EST - 4 months ago

Boundless Bio to Participate in the Leerink Global Healthcare Conference

Feb 12, 2026, 3:00 PM EST - 5 months ago

Boundless Bio Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026

Feb 5, 2026, 7:00 AM EST - 5 months ago

Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

2026-01-20T12:16:02.000Z - 5 months ago

Boundless Bio announces FDA accepted IND application of BBI-940

2026-01-20T12:15:45.000Z - 5 months ago

Boundless ceases enrollment of Phase 1/2 Potentiate trial of BBI-355, BBI-825

Jan 20, 2026, 7:00 AM EST - 5 months ago

Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway

Dec 3, 2025, 9:30 AM EST - 7 months ago

Boundless Bio Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 24, 2025, 7:00 AM EST - 7 months ago

Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

2025-11-05T12:06:32.000Z - 8 months ago

Boundless Bio reports Q3 EPS (62c), consensus (58c)

2025-11-05T12:05:53.000Z - 8 months ago

Boundless Bio sees cash runway into 1H28

Nov 5, 2025, 7:00 AM EST - 8 months ago

Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights

Nov 5, 2025, 7:00 AM EST - 8 months ago

Boundless Bio Quarterly report: Q3 2025

Nov 5, 2025, 7:00 AM EST - 8 months ago

Boundless Bio Earnings release: Q3 2025

Oct 13, 2025, 4:05 PM EDT - 9 months ago

Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

2025-08-11T10:15:45.000Z - 11 months ago

Boundless Bio price target lowered to $4 from $5 at H.C. Wainwright

2025-08-05T11:13:07.000Z - 11 months ago

Boundless Bio reports Q2 EPS (70c), consensus (65c)

Aug 5, 2025, 7:00 AM EDT - 11 months ago

Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 5, 2025, 7:00 AM EDT - 11 months ago

Boundless Bio Earnings release: Q2 2025

Aug 5, 2025, 7:00 AM EDT - 11 months ago

Boundless Bio Quarterly report: Q2 2025

2025-07-24T20:55:16.000Z - 1 year ago

Boundless Bio initiated with Early-Stage Biotech at Goldman Sachs

Jun 9, 2025, 9:20 AM EDT - 1 year ago

Boundless Bio Transcript: Goldman Sachs 46th Annual Global Healthcare Conference 2025

Jun 5, 2025, 4:58 PM EDT - 1 year ago

Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

2025-06-02T10:15:17.000Z - 1 year ago

Boundless Bio initiated with a Buy at H.C. Wainwright

2025-05-27T20:40:07.000Z - 1 year ago

Boundless Bio downgraded to Market Perform from Outperform at Leerink

May 27, 2025, 8:00 AM EDT - 1 year ago

Boundless Bio Transcript: Status Update

2025-05-23T20:05:14.000Z - 1 year ago

Boundless Bio discontinuing BBI-355 and BBI-825 programs

May 23, 2025, 4:01 PM EDT - 1 year ago

Boundless Bio Announces Portfolio Prioritization and Runway Extension

May 9, 2025, 7:00 AM EDT - 1 year ago

Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

May 8, 2025, 6:00 PM EDT - 1 year ago

Boundless Bio Earnings release: Q1 2025

May 8, 2025, 6:00 PM EDT - 1 year ago

Boundless Bio Quarterly report: Q1 2025

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Boundless Bio Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Boundless Bio Proxy statement: Proxy Filing

Apr 3, 2025, 7:00 AM EDT - 1 year ago

Boundless Bio to Participate in the Needham Virtual Healthcare Conference

2025-04-01T20:05:11.000Z - 1 year ago

Boundless Bio files $400M mixed securities shelf

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Boundless Bio Registration statement: Registration Filing

2025-03-27T11:07:19.000Z - 1 year ago

Boundless Bio reports Q4 EPS (74c) vs ($9.76) last year

Mar 27, 2025, 7:00 AM EDT - 1 year ago

Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Mar 27, 2025, 7:00 AM EDT - 1 year ago

Boundless Bio Annual report: Q4 2024

Mar 27, 2025, 7:00 AM EDT - 1 year ago

Boundless Bio Earnings release: Q4 2024

Mar 12, 2025, 11:20 AM EDT - 1 year ago

Boundless Bio Transcript: Leerink Global Healthcare Conference 2025

Feb 26, 2025, 7:00 AM EST - 1 year ago

Boundless Bio to Participate in the Leerink Global Healthcare Conference

2025-02-03T15:05:25.000Z - 1 year ago

Boundless Bio appoints Robert Doebele as CMO

Feb 3, 2025, 10:00 AM EST - 1 year ago

Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer

2024-12-13T14:05:18.000Z - 1 year ago

Boundless Bio downgraded to Neutral at Guggenheim after BBI-825 scrapped

Dec 12, 2024, 4:01 PM EST - 1 year ago

Boundless Bio Announces Pipeline and Leadership Updates

Dec 4, 2024, 3:30 PM EST - 1 year ago

Boundless Bio Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 7:00 AM EST - 1 year ago

Boundless Bio to Participate in the Piper Sandler Healthcare Conference

Nov 12, 2024, 2:30 PM EST - 1 year ago

Boundless Bio Transcript: Guggenheim’s Inaugural Healthcare Innovation Conference

Nov 7, 2024, 4:01 PM EST - 1 year ago

Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 7, 2024, 4:00 PM EST - 1 year ago

Boundless Bio Quarterly report: Q3 2024

Nov 7, 2024, 4:00 PM EST - 1 year ago

Boundless Bio Earnings release: Q3 2024

Nov 5, 2024, 7:00 AM EST - 1 year ago

Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference

Sep 18, 2024, 10:20 AM EDT - 1 year ago

Boundless Bio Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 11, 2024, 7:00 AM EDT - 1 year ago

Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference

Aug 12, 2024, 4:01 PM EDT - 2 years ago

Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results

Aug 12, 2024, 4:00 PM EDT - 2 years ago

Boundless Bio Quarterly report: Q2 2024

Aug 12, 2024, 4:00 PM EDT - 2 years ago

Boundless Bio Earnings release: Q2 2024

Jun 12, 2024, 3:20 PM EDT - 2 years ago

Boundless Bio Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

Jun 5, 2024, 7:00 AM EDT - 2 years ago

Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 13, 2024, 1:00 PM EDT - 2 years ago

Boundless Bio Transcript: The Citizens JMP Life Sciences Conference

May 13, 2024, 7:00 AM EDT - 2 years ago

Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights

May 13, 2024, 7:00 AM EDT - 2 years ago

Boundless Bio Quarterly report: Q1 2024

May 13, 2024, 7:00 AM EDT - 2 years ago

Boundless Bio Earnings release: Q1 2024

May 12, 2024, 7:00 AM EDT - 2 years ago

Boundless Bio Slides: Corporate Presentation

May 6, 2024, 8:00 AM EDT - 2 years ago

Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024

Apr 11, 2024, 8:00 AM EDT - 2 years ago

Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications

Apr 8, 2024, 8:00 AM EDT - 2 years ago

Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024

Mar 27, 2024, 6:55 PM EDT - 2 years ago

Boundless Bio Announces Pricing of Initial Public Offering

AlertsAndNews Jul. 3 at 8:03 PM

$BOLD TANG Capital Management LLC (10%+) purchased 107,463 shares at an average price of $2.50 (Form 4). Another form 4 here.

0 · Reply

JuggernautRaider Jul. 1 at 8:09 AM

$BOLD $ATRA i cannot wait to short these turds. Flush the toilet!🚽

0 · Reply

JuggernautRaider Jun. 30 at 1:11 PM

$BOLD @race2zerodo you want to short this dying company?

0 · Reply

AlertsAndNews Jun. 30 at 2:54 AM

$BOLD quite the 10%+er buy TANG Capital Management LLC (10%+) purchased 286,333 shares at an average price of $2.50 (Form 4).

0 · Reply

ikkydiphoenix Jun. 30 at 12:21 AM

$BOLD https://ca.investing.com/news/stock-market-news/tang-capital-management-acquires-714768-of-boundless-bio-stock-93CH-4712818

0 · Reply

JuggernautRaider Jun. 29 at 8:26 PM

$BOLD might short this shit, why not. Theur CEO is below average at best

0 · Reply

stockanalysis_ Jun. 27 at 2:19 PM

Weekly Gainers: $ILLR $SDOT $FCUV $ATLN $BOLD

0 · Reply

bananastand1203 Jun. 25 at 2:35 PM

3 · Reply

DayTrade_4Life Jun. 25 at 7:55 AM

👀Some stocks to watch for 25 June: AMS AZI WAVE FMFC SKYQ $ICCM $BOLD $UBXG 👉See Profile to Join Us.

0 · Reply

Bootsy_Collins Jun. 24 at 2:40 PM

$BOLD Shorting back to a dollar

1 · Reply

JuggernautRaider Jun. 24 at 2:12 PM

$BOLD looking juicy for action either way 🤫

0 · Reply

Jdiology Jun. 24 at 1:38 PM

$BOLD 🎯🎯

0 · Reply

stockwitsuser2449 Jun. 24 at 12:23 PM

$BOLD leaving this til the dust settles then will reenter for a short postion.

0 · Reply

ShKumaresan Jun. 24 at 2:54 AM

$BOLD $BLZE $QNT Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today https://stocktwits.com/news-articles/markets/equity/why-did-bold-blze-qnt-stocks-surge-to-52-week-highs-today/cZKUHYtR7OQ

0 · Reply

StocktwitsNews Jun. 24 at 2:53 AM

Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today $BLZE $BOLD $QNT $CRWV https://stocktwits.com/news/equity/markets/why-did-bold-blze-qnt-stocks-surge-to-52-week-highs-today/cZKUHYtR7OQ

0 · Reply

TeamBullish Jun. 24 at 2:50 AM

The Stock Market made me a millionaire, maybe that’s why I show up everyday, and truly believe in it. Anyone can make the American dream come true. $ATLN $SPCX $FCUV $SPY $BOLD

2 · Reply

Stock_Catcher Jun. 24 at 1:46 AM

Wealthy Wednesday Watchlist Continuation $CIIT $CRMT $FOFO $BOLD $YMAT

0 · Reply

SilentNome Jun. 24 at 1:44 AM

$BOLD they will drag this to $1

0 · Reply

topstockalerts Jun. 24 at 1:43 AM

Top Gainers $ATLN $ADTX $FCUV $BOLD $CIIT

0 · Reply

SadyK189 Jun. 24 at 12:56 AM

Top Stocks to watch tomorrow 2 / 2: $FCUV $OTLK $BOLD $LFS $NIXX OTLK: Initially alerted at 0.54. Kept posting about it regularly. Currently at 1.70 with key support zone at 1.10 - 1.23 now. Next key level to test 2.05 - 2.25. FCUV: Looking good on 4hours chart. 3.2 - 3.5 is acting as key support zone. Next key level to test 5.4 - 5.8. Currently at 4.68 LFS: Looking good on 4hours chart and held key support zone of 1.95 - 2.15 nicely so far. Next key level to test 3.5 - 3.85. Currently at 2.98 BOLD: Good close of daily candle. Key support zone at 2 - 2.20. Next key level to test 3.15 - 3.40. Currently at 2.68 NIXX is moving slowly and steadily but nicely on daily chart. Updated support zone at 1 - 1.09. Next key level to test 1.9 - 2.15. Currently at 1.47

2 · Reply

Spicy_Trade Jun. 24 at 12:45 AM

Boundless Bio, Inc. ( $BOLD ) SpicyTrade - Daily Stock Analysis https://youtu.be/bqULID6taIg?si=Rj2vP_KadyhrvQWi

0 · Reply

GSP Jun. 24 at 12:43 AM

$ATLN $BOLD $CRMT $INFQ $SPY

0 · Reply

Market Cap	56.16M
Revenue (ttm)	0.00
Net Income (ttm)	-58.20M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	143,900
Avg Vol	1,502,834
Day's Range	N/A - N/A
Shares Out	22.46M
Stochastic %K	79%
Beta	-0.07
Analysts	Hold
Price Target	$4.00